JL, d. S., FR, R., GG, d. M., PV, F., LCS, T., & AC, d. M. (2021). Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment. Dove Medical Press.
Cita Chicago Style (17a ed.)JL, da Silva, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, y de Melo AC. Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment. Dove Medical Press, 2021.
Cita MLA (8a ed.)JL, da Silva, et al. Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.